Equine Healthcare Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2028

TMR's report on the global equine healthcare market studies past as well as current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2028. The report provides revenue of the global equine healthcare market for the period 2017-2028, considering 2020 as the base year and 2028 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global equine healthcare market during the forecast period.

The report has been prepared after an extensive primary and secondary research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involved referring to key players' literature, annual reports, press releases, and relevant documents to understand the global equine healthcare market.

Secondary research included Internet sources, statistical data from government agencies, websites, company presentations, sales data, and trade associations. Analysts have employed a combination of top-down and bottom-up approaches to study various phenomenon in the global equine healthcare market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global equine healthcare market. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global equine healthcare market.

The report delves into the competition landscape of the global equine healthcare market. Key players operating in the global equine healthcare market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global equine healthcare market that have been profiled in this report.

Key Questions Answered:

What is the scope of growth of companies in the global equine healthcare market?

What will be the Y-o-Y growth of the global equine healthcare market between 2017 and 2028?

What is the influence of changing trends in technologies on the global equine healthcare market?

Which factors are anticipated to hamper the growth of the global equine healthcare market during the forecast period?

Which are the leading companies in the global equine healthcare market?

Research Methodology

A unique research methodology has been utilized by TMR to conduct comprehensive research on the growth of the global equine healthcare market and arrive at conclusions on its growth prospects. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.

Secondary methods referred to by analysts during production of the global equine healthcare market report include statistics from company annual reports, SEC filings, company websites, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of TMR's study on the equine healthcare market as primary methods.

These primary and secondary methods have provided exclusive information during interviews, which serves as a validation from the equine healthcare market leaders. Access to an extensive internal repository and external proprietary databases enabled this report to address specific details and questions about the global equine healthcare market with accuracy. The study also uses the top-down approach to assess the revenues for each segment and the bottom-up approach to counter-validate them. This has helped in reaching TMR's estimates on future prospects of the global equine healthcare market more reliably and accurately.

Product Code: TMRGL1603

1. Preface

1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Equine Healthcare Market

4. Market Overview

4.1. Introduction
- 4.1.1. Product Type Definition
- 4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Opportunities
4.4. Global Equine Healthcare Market Analysis and Forecast, 2017-2028
- 4.4.1. Market Revenue Projections (US$ Bn)

5. Key Insights

5.1. Coagulation Disorders & Coagulation Pathways: Overview
5.2. Epidemiology: Coagulation Disorders
5.3. Regulatory Framework
5.4. Reimbursement Scenario
5.5. Equine Healthcare Market: Pricing Analysis
5.6. Equine Healthcare Market: Value Chain Analysis
5.7. Equine Healthcare Market: Porter's Five Forces Analysis

6. Global Equine Healthcare Market Analysis and Forecast, by Product Type

6.1. Introduction & Definition
- 6.1.1. Key Findings / Developments
6.2. Global Equine Healthcare Market Value Forecast, by Product Type, 2017-2028
- 6.2.1. Drugs
  - 6.2.1.1. Anti-infectives
  - 6.2.1.2. Anti-inflammatory
  - 6.2.1.3. Parasiticides
  - 6.2.1.4. Others
- 6.2.2. Vaccines
  - 6.2.2.1. Inactivated
  - 6.2.2.2. Live Attenuated
  - 6.2.2.3. Recombinant
  - 6.2.2.4. Others
- 6.2.3. Medical Supplemental Feed
  - 6.2.3.1. Minerals
  - 6.2.3.2. Vitamins
  - 6.2.3.3. Protein
  - 6.2.3.4. Enzyme
  - 6.2.3.5. Others
6.3. Global Equine Healthcare Market Attractiveness Analysis, by Product Type

7. Global Equine Healthcare Market Analysis and Forecast, by Disease Type

7.1. Introduction & Definition
- 7.1.1. Key Findings / Developments
7.2. Global Equine Healthcare Market Value Forecast, by Disease Type, 2017-2028
- 7.2.1. West Nile Virus
- 7.2.2. Equine Rabies
- 7.2.3. Potomac Horse Fever
- 7.2.4. Tetanus
- 7.2.5. Equine Influenza
- 7.2.6. Equine Herpes Virus
- 7.2.7. Equine Encephalomyelitis
- 7.2.8. Others (equine infectious anemia)
7.3. Global Equine Healthcare Market Attractiveness Analysis, by Disease Type

8. Global Equine Healthcare Market Analysis and Forecast, by Distribution Channel

8.1. Introduction & Definition
- 8.1.1. Key Findings / Developments
8.2. Global Equine Healthcare Market Value Forecast, by Distribution Channel, 2017-2028
- 8.2.1. Veterinary Hospitals & Clinics
- 8.2.2. Retail Pharmacies & Drug Stores
- 8.2.3. Others

9. Global Equine Healthcare Market Analysis and Forecast, by Region

9.1. Key Findings
9.2. Global Equine Healthcare Market Value Forecast, by Region
- 9.2.1. North America
- 9.2.2. Europe
- 9.2.3. Asia Pacific
- 9.2.4. Latin America
- 9.2.5. Middle East & Africa
9.3. North America Equine Healthcare Market Attractiveness Analysis, by Region

10. North America Equine Healthcare Market Analysis and Forecast

10.1. Introduction
- 10.1.1. Key Findings
10.2. North America Equine Healthcare Market Value (US$ Bn) Forecast, by Product Type, 2017-2028
- 10.2.1. Drugs
  - 10.2.1.1. Anti-infectives
  - 10.2.1.2. Anti-infectives
  - 10.2.1.3. Anti-inflammatory
  - 10.2.1.4. Parasiticides
  - 10.2.1.5. Others
  - 10.2.1.6. Transfer Lifts
  - 10.2.1.7. Door Openers
  - 10.2.1.8. Others
- 10.2.2. Vaccines
  - 10.2.2.1. Inactivated
  - 10.2.2.2. Live Attenuated
  - 10.2.2.3. Recombinant
  - 10.2.2.4. Others
  - 10.2.2.5. Others
- 10.2.3. Medical Supplemental Feed
  - 10.2.3.1. Minerals
  - 10.2.3.2. Vitamins
  - 10.2.3.3. Protein
  - 10.2.3.4. Enzyme
  - 10.2.3.5. Others
10.3. North America Equine Healthcare Market Value (US$ Mn) Forecast, by Disease Type, 2017-2027
- 10.3.1. West Nile Virus
- 10.3.2. Equine Rabies
- 10.3.3. Potomac Horse Fever
- 10.3.4. Tetanus
- 10.3.5. Equine Influenza
- 10.3.6. Equine Herpes Virus
- 10.3.7. Equine Encephalomyelitis
- 10.3.8. Others (equine infectious anemia)
10.4. North America Equine Healthcare Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027
- 10.4.1. Veterinary Hospitals & Clinics
- 10.4.2. Retail Pharmacies & Drug Stores
- 10.4.3. Others
10.5. North America Equine Healthcare Market Value (US$ Mn) Forecast, by Country, 2017-2027
- 10.5.1. U.S.
- 10.5.2. Canada
10.6. North America Equine Healthcare Market Attractiveness Analysis
- 10.6.1. By Product Type
- 10.6.2. By Disease Type
- 10.6.3. By Distribution Channel
- 10.6.4. By Country

11. Europe Equine Healthcare Market Analysis and Forecast

11.1. Introduction
- 11.1.1. Key Findings
11.2. Europe Equine Healthcare Market Value (US$ Bn) Forecast, by Product Type, 2017-2028
- 11.2.1. Drugs
  - 11.2.1.1. Anti-infectives
  - 11.2.1.2. Anti-infectives
  - 11.2.1.3. Anti-inflammatory
  - 11.2.1.4. Parasiticides
  - 11.2.1.5. Others
  - 11.2.1.6. Transfer Lifts
  - 11.2.1.7. Door Openers
  - 11.2.1.8. Others
- 11.2.2. Vaccines
  - 11.2.2.1. Inactivated
  - 11.2.2.2. Live Attenuated
  - 11.2.2.3. Recombinant
  - 11.2.2.4. Others
  - 11.2.2.5. Others
- 11.2.3. Medical Supplemental Feed
  - 11.2.3.1. Minerals
  - 11.2.3.2. Vitamins
  - 11.2.3.3. Protein
  - 11.2.3.4. Enzyme
  - 11.2.3.5. Others
11.3. Europe Equine Healthcare Market Value (US$ Mn) Forecast, by Disease Type, 2017-2027
- 11.3.1. West Nile Virus
- 11.3.2. Equine Rabies
- 11.3.3. Potomac Horse Fever
- 11.3.4. Tetanus
- 11.3.5. Equine Influenza
- 11.3.6. Equine Herpes Virus
- 11.3.7. Equine Encephalomyelitis
- 11.3.8. Others (Equine Infectious Anemia)
11.4. Europe Equine Healthcare Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027
- 11.4.1. Veterinary Hospitals & Clinics
- 11.4.2. Retail Pharmacies & Drug Stores
- 11.4.3. Others
11.5. Europe Equine Healthcare Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
- 11.5.1. Germany
- 11.5.2. U.K.
- 11.5.3. France
- 11.5.4. Spain
- 11.5.5. Italy
- 11.5.6. Rest of Europe
11.6. Europe Equine Healthcare Market Attractiveness Analysis
- 11.6.1. By Product Type
- 11.6.2. By Disease Type
- 11.6.3. By Distribution Channel
- 11.6.4. By Country/Sub-region

12. Asia Pacific Equine Healthcare Market Analysis and Forecast

12.1. Introduction
- 12.1.1. Key Findings
12.2. Asia Pacific Equine Healthcare Market Value (US$ Bn) Forecast, by Product Type, 2017-2028
- 12.2.1. Drugs
  - 12.2.1.1. Anti-infectives
  - 12.2.1.2. Anti-infectives
  - 12.2.1.3. Anti-inflammatory
  - 12.2.1.4. Parasiticides
  - 12.2.1.5. Others
  - 12.2.1.6. Transfer Lifts
  - 12.2.1.7. Door Openers
  - 12.2.1.8. Others
- 12.2.2. Vaccines
  - 12.2.2.1. Inactivated
  - 12.2.2.2. Live Attenuated
  - 12.2.2.3. Recombinant
  - 12.2.2.4. Others
  - 12.2.2.5. Others
- 12.2.3. Medical Supplemental Feed
  - 12.2.3.1. Minerals
  - 12.2.3.2. Vitamins
  - 12.2.3.3. Protein
  - 12.2.3.4. Enzyme
  - 12.2.3.5. Others
12.3. Asia Pacific Equine Healthcare Market Value (US$ Mn) Forecast, by Disease Type, 2017-2027
- 12.3.1. West Nile Virus
- 12.3.2. Equine Rabies
- 12.3.3. Potomac Horse Fever
- 12.3.4. Tetanus
- 12.3.5. Equine Influenza
- 12.3.6. Equine Herpes Virus
- 12.3.7. Equine Encephalomyelitis
- 12.3.8. Others (equine infectious anemia)
12.4. Asia Pacific Equine Healthcare Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027
- 12.4.1. Veterinary Hospitals & Clinics
- 12.4.2. Retail Pharmacies & Drug Stores
- 12.4.3. Others
12.5. Asia Pacific Equine Healthcare Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
- 12.5.1. China
- 12.5.2. Japan
- 12.5.3. India
- 12.5.4. Australia & New Zealand
- 12.5.5. Rest of Asia Pacific
12.6. Asia Pacific Equine Healthcare Market Attractiveness Analysis
- 12.6.1. By Product Type
- 12.6.2. By Disease Type
- 12.6.3. By Distribution Channel
- 12.6.4. By Country/Sub-region

13. Latin America Equine Healthcare Market Analysis and Forecast

13.1. Introduction
- 13.1.1. Key Findings
13.2. Latin America Equine Healthcare Market Value (US$ Bn) Forecast, by Product Type, 2017-2028
- 13.2.1. Drugs
  - 13.2.1.1. Anti-infectives
  - 13.2.1.2. Anti-infectives
  - 13.2.1.3. Anti-inflammatory
  - 13.2.1.4. Parasiticides
  - 13.2.1.5. Others
  - 13.2.1.6. Transfer Lifts
  - 13.2.1.7. Door Openers
  - 13.2.1.8. Others
- 13.2.2. Vaccines
  - 13.2.2.1. Inactivated
  - 13.2.2.2. Live Attenuated
  - 13.2.2.3. Recombinant
  - 13.2.2.4. Others
  - 13.2.2.5. Others
- 13.2.3. Medical Supplemental Feed
  - 13.2.3.1. Minerals
  - 13.2.3.2. Vitamins
  - 13.2.3.3. Protein
  - 13.2.3.4. Enzyme
  - 13.2.3.5. Others
13.3. Latin America Equine Healthcare Market Value (US$ Mn) Forecast, by Disease Type, 2017-2027
- 13.3.1. West Nile Virus
- 13.3.2. Equine Rabies
- 13.3.3. Potomac Horse Fever
- 13.3.4. Tetanus
- 13.3.5. Equine Influenza
- 13.3.6. Equine Herpes Virus
- 13.3.7. Equine Encephalomyelitis
- 13.3.8. Others (equine infectious anemia)
13.4. Latin America Equine Healthcare Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027
- 13.4.1. Veterinary Hospitals & Clinics
- 13.4.2. Retail Pharmacies & Drug Stores
- 13.4.3. Others
13.5. Latin America Equine Healthcare Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
- 13.5.1. Brazil
- 13.5.2. Mexico
- 13.5.3. Rest of Latin America Latin America
13.6. Latin America Equine Healthcare Market Attractiveness Analysis
- 13.6.1. By Product Type
- 13.6.2. By Disease Type
- 13.6.3. By Distribution Channel
- 13.6.4. By Country/Sub-region

14. Middle East & Africa Equine Healthcare Market Analysis and Forecast

14.1. Introduction
- 14.1.1. Key Findings
14.2. Middle East & Africa Equine Healthcare Market Value (US$ Bn) Forecast, by Product Type, 2017-2028
- 14.2.1. Drugs
  - 14.2.1.1. Anti-infectives
  - 14.2.1.2. Anti-infectives
  - 14.2.1.3. Anti-inflammatory
  - 14.2.1.4. Parasiticides
  - 14.2.1.5. Others
  - 14.2.1.6. Transfer Lifts
  - 14.2.1.7. Door Openers
  - 14.2.1.8. Others
- 14.2.2. Vaccines
  - 14.2.2.1. Inactivated
  - 14.2.2.2. Live Attenuated
  - 14.2.2.3. Recombinant
  - 14.2.2.4. Others
  - 14.2.2.5. Others
- 14.2.3. Medical Supplemental Feed
  - 14.2.3.1. Minerals
  - 14.2.3.2. Vitamins
  - 14.2.3.3. Protein
  - 14.2.3.4. Enzyme
  - 14.2.3.5. Others
14.3. Middle East & Africa Equine Healthcare Market Value (US$ Mn) Forecast, by Disease Type, 2017-2027
- 14.3.1. West Nile Virus
- 14.3.2. Equine Rabies
- 14.3.3. Potomac Horse Fever
- 14.3.4. Tetanus
- 14.3.5. Equine Influenza
- 14.3.6. Equine Herpes Virus
- 14.3.7. Equine Encephalomyelitis
- 14.3.8. Others (equine infectious anemia)
14.4. Middle East & Africa Equine Healthcare Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027
- 14.4.1. Veterinary Hospitals & Clinics
- 14.4.2. Retail Pharmacies & Drug Stores
- 14.4.3. Others
14.5. Middle East & Africa Equine Healthcare Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
- 14.5.1. GCC Countries
- 14.5.2. South Africa
- 14.5.3. Rest of Middle East & Africa
14.6. Middle East & Africa Equine Healthcare Market Attractiveness Analysis
- 14.6.1. By Product Type
- 14.6.2. By Disease Type
- 14.6.3. By Distribution Channel
- 14.6.4. By Country/Sub-region

15. Competition Landscape

15.1. Market Player - Competition Matrix (by tier and size of companies)
15.2. Market Share / Position Analysis, by Company, 2020
15.3. Competitive Business Strategies
15.4. Company Profiles
- 15.4.1. Bayer AG (Bayer Animal Healthcare)
  - 15.4.1.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 15.4.1.2. Financial Analysis
  - 15.4.1.3. Growth Strategies
  - 15.4.1.4. SWOT Analysis
- 15.4.2. Boehringer Ingelheim
  - 15.4.2.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 15.4.2.2. Financial Analysis
  - 15.4.2.3. Growth Strategies
  - 15.4.2.4. SWOT Analysis
- 15.4.3. Ceva Sante Animale
  - 15.4.3.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 15.4.3.2. Financial Analysis
  - 15.4.3.3. Growth Strategies
  - 15.4.3.4. SWOT Analysis
- 15.4.4. Eli Lilly and Company (Elanco)
  - 15.4.4.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 15.4.4.2. Financial Analysis
  - 15.4.4.3. Growth Strategies
  - 15.4.4.4. SWOT Analysis
- 15.4.5. Equine Products U.K. Ltd.
  - 15.4.5.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 15.4.5.2. Financial Analysis
  - 15.4.5.3. Growth Strategies
  - 15.4.5.4. SWOT Analysis
- 15.4.6. Merck & Co. (Merck Animal Healthcare)
  - 15.4.6.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 15.4.6.2. Financial Analysis
  - 15.4.6.3. Growth Strategies
  - 15.4.6.4. SWOT Analysis
- 15.4.7. Sanofi (Merial)
  - 15.4.7.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 15.4.7.2. Financial Analysis
  - 15.4.7.3. Growth Strategies
  - 15.4.7.4. SWOT Analysis
- 15.4.8. Purina Animal Nutrition LLC
  - 15.4.8.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 15.4.8.2. Financial Analysis
  - 15.4.8.3. Growth Strategies
  - 15.4.8.4. SWOT Analysis
- 15.4.9. Vetoquinol S.A.
  - 15.4.9.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 15.4.9.2. Financial Analysis
  - 15.4.9.3. Growth Strategies
  - 15.4.9.4. SWOT Analysis
- 15.4.10. Zoetis
  - 15.4.10.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 15.4.10.2. Financial Analysis
  - 15.4.10.3. Growth Strategies
  - 15.4.10.4. SWOT Analysis